Biotech · Public company · Scottsdale, AZ, US
Journey Medical Corp
Ticker DERM · SEC CIK 0001867066
Track this companyFree. Adds Journey Medical Corp to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline15
- DFD-29Phase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- DoxycyclinePhase 3 · Papulopustular RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- glycopyrronium Topical WipesPhase 3 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Dose 1 of glycopyrrolate, 2.0% QDPhase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Dose 1 of glycopyrronium, 2.5% QDPhase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Dose 2 of glycopyrrolate, 3.0% QDPhase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Dose 2 of glycopyrronium, 3.75% QDPhase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- glycopyrrolate, 1.0%Phase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- glycopyrrolate, 2.0%Phase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- glycopyrrolate, 3.0%Phase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- glycopyrrolate, 4.0%Phase 2 · HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Glycopyrronium cloth, 2.4%Phase 2 · Palmar HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Palmar HyperhidrosisClinicalTrials.gov · fetched Nov 12, 2026
- Minocycline hydrochloride capsulesPhase 1 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 WeeksPHASE1 · COMPLETED · started Sep 30, 2022ClinicalTrials.gov NCT05597462 · fetched Nov 12, 2026
- A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)PHASE3 · COMPLETED · started Mar 29, 2022ClinicalTrials.gov NCT05343455 · fetched Nov 12, 2026
- A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.PHASE3 · COMPLETED · started Mar 14, 2022ClinicalTrials.gov NCT05296629 · fetched Nov 12, 2026
- A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar HyperhidrosisPHASE2 · COMPLETED · started Feb 22, 2019ClinicalTrials.gov NCT03880266 · fetched Nov 12, 2026
- Study of Glycopyrronium in Subjects With Axillary HyperhidrosisPHASE3 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02530294 · fetched Nov 12, 2026
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary HyperhidrosisPHASE3 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02553798 · fetched Nov 12, 2026
- Study of Glycopyrronium in Axillary HyperhydrosisPHASE3 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02530281 · fetched Nov 12, 2026
- Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02129660 · fetched Nov 12, 2026
- A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary HyperhidrosisPHASE2 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT02016885 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 26, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 21, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 26, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 25, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 26, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 28, 2025 · fetched Nov 12, 2026